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Abstract
Mitochondria represent a chimera of macromolecules encoded either in
the organellar genome, mtDNA, or in the nuclear one. If the pathway of
protein targeting to different sub-compartments of mitochondria was
relatively well studied, import of small noncoding RNAs into mamma-
lian mitochondria still awaits mechanistic explanations and its func-
tional issues are often not understood thus raising polemics. At the
same time, RNA mitochondrial import pathway has an obvious attrac-
tiveness as it appears as a unique natural mechanism permitting to
address nucleic acids into the organelles. Deciphering the function(s) of
imported RNAs inside the mitochondria is extremely complicated due
to their relatively low abundance, which suggests their regulatory role.
We previously demonstrated that mitochondrial targeting of small non-
coding RNAs able to speciﬁcally anneal with the mutant mitochondrial
DNA led to a decrease of the mtDNA heteroplasmy level by inhibiting
mutant mtDNA replication. We then demonstrated that increasing level
of expression of such antireplicative recombinant RNAs increases
signiﬁcantly the antireplicative effect. In this report, we present a new
data investigating the possibility to establish a CRISPR-Cas9 system
targeting mtDNA exploiting of the pathway of RNA import into mito-
chondria. Mitochondrially addressed Cas9 versions and a set of mito-
chondrially targeted guide RNAs were tested in vitro and in vivo and
their effect on mtDNA copy number was demonstrated. So far, the sys-
tem appeared as more complicated for use than previously found for
nuclear DNA, because only application of a pair of guide RNAs pro-
duced the effect of mtDNA depletion. We discuss, in a critical way,
these results and put them in a broader context of polemics concerning
the possibilities of manipulation of mtDNA in mammalians. The ﬁnd-
ings described here prove the potential of the RNA import pathway as a
tool for studying mtDNA and for future therapy of mitochondrial disor-
ders. © 2018 The Authors. IUBMB Life published by Wiley Periodicals,
Inc. on behalf of International Union of Biochemistry and Molecular
Biology, 00(00):1–7, 2018
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INTRODUCTION
Mitochondria are intracellular organelles involved in a multi-
tude of mechanisms ranging from respiration to apoptosis
(1, 2). Their implication in metabolic, bioenergetics, and
homeostatic processes make them indispensable for virtually
all eukaryotic cells with only few contrary examples of
replacement of essential pathways by alternative bacterial
counterparts (3). Mitochondria possess their own genome,
mtDNA, which can be organized in different ways among spe-
cies, encoding between one and several dozens of proteins,
different number of tRNAs and rRNAs. The most of proteins
and some small RNAs are targeted from the nucleoplasmic
compartment in different sub-compartments of mitochondria
(4, 5). These sub-compartments are deﬁned by a complex bi-
membrane envelope with several multiprotein complexes-
receptors. Loss of function(s) of mitochondria has drastic
effect on the overall cellular functioning, in humans
Abbreviations: mtDNA, mitochondrial DNA; gRNA, guide RNA; KSS,
Kearns Sayre Syndrome; PCR, polymerase chain reaction; RNP,
ribonucleoprotein
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Research Communication
provoking severe and mostly incurable diseases (6). Both to
study mitochondrial functions and to try to cure mtDNA-
caused dysfunctions, it is essential to be able to address
directly mtDNA, but it still remains an important challenge.
Last years, several alternative approaches to manipulate
mtDNA were developed. One successful strategy was based
on the TALEN technology, adapted for mitochondria (mito-
TALENs) (7–10), the second – on sequence-speciﬁc designed
Zn-ﬁngers nucleases targeted in the organelles (11–13). As
one of the largely used approach to manipulate DNA in vivo is
currently the CRISPR system (in all its versions), the legiti-
mate idea was to apply it to mitochondria (discussed in Refer-
ence (14)). Some attempts seemed to be promising if even
provoking debate (15). In the opinion of other researchers,
mtDNA could be even the single known target impossible for
“CRISPRization” (16). So far, to investigate mitochondrial
functions, dysfunction and evolutionary aspects such a system
would be of great help.
For many years, our team invested in studying of the path-
way of RNA targeting into mitochondria, in yeast Saccharomy-
ces cerevisiae and in human cells. We discovered several
important features of this mechanism (17–25) and exploited it
to address into mitochondria active RNA molecules able to
either functional replace of the mutant ones (strategy called as
“allotopic”) (26, 27) or to affect in a speciﬁc way the propaga-
tion of mutant mtDNA (“anti-replication” strategy) (28–30). We
now tried to adapt our know-how to develop the CRISPR-Cas9
system for human mitochondria using cultured human cells.
The results described herein are in favor of the possibility of
such a system, but it is clear that additional adaptation and
optimization will be required to make it as efﬁcient and speciﬁc
as in nucleus.
MATERIAL AND METHODS
Strains, Lines, Antibodies
Escherichia coli XL1-Blue (Stratagen) were used for all cloning
procedures and Rosetta™ (DE3) – for overexpression of hCas9.
Human KSS cells were a stable cybrid line based on 143B
osteocarcinoma rho0 cells and contained 65% of the deletion in
mtDNA (m.8363-15438del) (30). Human HepG2 cells, issued
from hepatocyte carcinoma and available commercially, were
used as wild type line. Flp-In™ T-rex™ cells permitting con-
trolled insertion of the MTSCOX8A-hCas9 gene in the unique FRT
site were purchased in Invitrogen (Carlsbad, CA, USA).
For Western analysis, we used primary monoclonal anti-
bodies against Cas9 (Diagenode), polyclonal antibodies against
enolase (C-19, Santa Cruz Biotechnolgy, Dallas, TX, USA) and
PNPase (Abcam, Cambridge, UK), TOM20 (Abcam), and corre-
sponding secondary antibodies from either GE Healthcare
(Pittsburgh, PA, USA) or Molecular Probes (Life Technologies,
Waltham, MA, USA).
In Vitro MtDNA Cleavage Assay
Mature hCas9 (devoid of NLS sequence) was puriﬁed after over-
expression from the pMJ806 plasmid, as described in Reference
(31). The cleavage substrates represented PCR-ampliﬁed frag-
ments of mtDNA of various sizes (1–4 kb) containing (or not con-
taining) the target sequences. gRNAs were produced by T7
transcription from DNA fragments generated by annealing of
two oligonucleotides followed by PCR. The cleavage assay con-
tained 500 nM of gRNA, 500 nM of recombinant hCas9, and
300 ng of the template DNA, as described elsewhere (31). For
the assay of native mtDNA cleavage, after incubation with hCas9
the reaction mix was deproteinized by phenol-chloroform
extraction and treated with endonuclease BlpI (FastDigest) to
facilitate the Southern blot identiﬁcation of Cas9 cleavage sites.
RNA Mitochondrial Import Assay
Mitochondria and mitochondrial RNA were isolated as described
previously (29, 30). Total and mitochondrial RNA were sepa-
rated by urea-PAGE and analyzed by Northern hybridization
using 32P-50-labeled oligonucleotide probes. As a control of cyto-
solic contamination, we tested 5.8S rRNA or tRNAMet, as a con-
trol of the integrity of mitochondrial RNA, mt tRNALys.
Heteroplasmy and MtDNA Content Measurements
The heteroplasmy level of the KSS deletion was measured by
qPCR with the Bio-Rad qPCR iCycler CFX96™ as described
(30) and always included two calibration series corresponding
to either only wild type or all (wild type and deleted)
mtDNA. The level of heteroplasmy was then calculated as the
% = (1−mtDNAwt/total) × 100. To measure the mtDNA copy
number by qPCR, the mitochondrial gene MT-RNR1 (12S rRNA)
and nuclear gene TST (thiosulfate sulfurtransferase) were
quantiﬁed; each assay included two calibration series for abso-
lute quantiﬁcation. Data obtained on independently cultivated
cells (n = 3) by 3–4 independent qPCR measurements were sta-
tistically processed using the two-tailed Student’s t-test; values
of P ≤ 0.05 were considered to be statistically signiﬁcant.
Microscopy
Colocalisation analyses were performed by either confocal
microscopy of ﬁxed permeabilized samples with the Zeiss LSM
700 system with antibodies against Cas9 or TOM20 (presented
in the result section) or super-resolution PALM/STORM with
Cas9 antibodies and the co-expressed fusion TWINKLE-mEos2
(not presented here but providing similar results). The images
were analyzed with ImageJ software.
Informatics
Secondary structures of mito-gRNAs were predicted using the
Mfold software. Analysis of the annealing between mito-gRNAs
and the mtDNA was performed by RNAcofoldweb server, Univer-
sity of Vienna. To estimate melting temperatures for RNA–DNA
duplexes, we used IDT Sci-Tools OligoAnalyzer 3.1 software.
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RESULTS
Recombinant Guide RNAs can be Targeted into Human
Mitochondria
We designed guide RNAs targeting different regions of either
wild type mtDNA or speciﬁcally recognizing the border of the
KSS deletion, m.8363-15438del (Fig. 1A). To make gRNAs tar-
getable in mitochondria, we introduced import determinants
described in our previous studies. We used hairpin structures F
and D (Fig. 1B), initially described in Selex experiments and
further successfully tested for anti-replication strategy in a vari-
ety of cell lines (28–30, 32, 33). When designing gRNAs, we ﬁrst
analyzed in sillico predicted secondary structures, to ensure
the correct folding of the import determinants and of the hair-
pins recognized by the Cas9 protein.
We then tested if these gRNAs are mitochondrially addressed.
To this end, we transiently transfected cultured cells with corre-
sponding T7 transcripts and analyzed total RNA and RNA isolated
from puriﬁed mitochondria by Northern hybridization. Control
hybridizations show that isolated mitochondria were devoid of
nuclear or cytosolic contamination (5.8S rRNA) and contained
intact mtDNA derived transcripts. For gRNAs tested, we observed
the mitochondrial targeting with slightly different but comparable
efﬁciencies (Fig. 1C). Surprisingly, gRNA molecules lacking the
import determinants were also detected in puriﬁed mitochondria,
suggesting that gRNA hairpins can substitute them.
Cas9 Protein can be Targeted into Human
Mitochondria
The enzymatic part of the system we developed was based on
the Streptococcus pyogenes Cas9 gene adapted for expression
in human cells (31). The coding sequence of the gene was modi-
ﬁed to eliminate the C-terminal NLS motif, and to add the mito-
chondrial targeting signal of the mitochondrially imported
Cox8A protein at the N-terminus (Fig. 2A). The resulting con-
struct, MTSCOX8A-hCas9 was tested for expression and mito-
chondrial targeting in cultured human cells. We ﬁrst
demonstrated mitochondrial import of MTSCOX8A-hCas9 in
model HepG2 cells by Western blot on puriﬁed mitochondria
(Fig. 2C). In parallel, we developed a cell line, further referred
for as HEK293-T-Rex-MTSCOX8A-hCas9, expressing the
MTSCOX8A-hCas9 in an inducible way, by using the Flp-In™
T-Rex™ system (Invitrogen), and tested the mitochondrial local-
ization of MTSCOX8A-hCas9 by immunoﬂuorescent microscopy
(Fig. 2B).
Mt-gRNA can Speciﬁcally Cleave Mitochondrial DNA
In Vitro
The two components of the system (mito-gRNAs) and the
mature form of MTSCOX8A-hCas9 were then tested for cleavage
activity in in vitro assays. First, we demonstrated that two puri-
ﬁed components (T7 polymerase generated mito-gRNA and
recombinant hCas9) are able to cleave the PCR fragment
FIG 1
Design of mito-gRNAs. (A) Genetic map of human wild type mtDNA (at the left) and of the deleted “KSS” mtDNA (at the right).
Pointed line indicated the KSS deletion. At the bottom, the NCR of mtDNA is enlarged: CSB, OriH, promoters, and D-loop region
are indicated. Locations of the sequences that are targeted by mito-gRNAs are indicated in red; (B) Predicted 2D structures of
mito-gRNAs. Linear orange part corresponds to the sequence targeting mtDNA. Orange structured part is the conserved
sequence recognized by the Cas9 enzyme. Red or blue hairpins represent mitochondrial import determinants “F” or “D”;
(C) Mitochondrial import of mito-gRNAs. Results of northern-hybridization are presented. Probes are indicated at the right of the
panels, the mito-gRNAs used for cell transfection are indicated earlier, as well as the origin of RNA (mitochondrial or total). Mito-
chondrial import efﬁciencies (% of the cellular pool present in mitochondrial fraction) are indicated below the panels.
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containing the target sequence (Fig. 2D). These assays gave an
obvious positive result: only the target, but not a control mtDNA
sequence was recognized and cleaved. The gRNA versions
bearing the hairpin D at the 50-end (Fig. 1B), as well as noncod-
ing region (NCR)2 gRNA, could not induce a complete cleavage
of the DNA substrate and thus have been excluded from further
analysis. Next, we used mitochondrial lysates of human cells
expressing MTSCOX8A-hCas9 as a source of protein. The efﬁ-
ciency of this system was clearly lower than with puriﬁed
recombinant protein, but still provided a speciﬁc cleavage
(Fig. 2E). Taking into account that in vivo mitochondrial DNA is
organized in a complex way, forming the nucleoid nucleopro-
tein complexes, we also assayed the cleavage of native mtDNA,
isolated from puriﬁed mitochondria without deproteinization.
The data obtained also demonstrated that the target sequence
can be partially cleaved (Fig. 2F). Noteworthy, we detected only
cleavage induced by gRNA WT + F targeting a region of Cyt b
gene (producing a fragment 1.9 kb detected by Southern blot).
Another gRNA NCR + F could induce only a partial cleavage
(producing 1.3 kb fragment) of puriﬁed mtDNA.
The Effect of Mitochondrial Targeting of CRISPR-Cas9
System on MtDNA In Vivo
We next analyzed the effect of the mitochondrial CRISPR-Cas9
system in vivo. The assays were performed either by transient
transfection of cultured cells with vectors expressing the
MTSCOX8A-hCas9 protein together with mito-gRNAs, or by
induction of the protein expression in the cell line HEK293-T-
FIG 2
Design of MTSCOX8A-hCas9. (A) Constructs containing the Cas9 gene. The NLS signal is in red, the COX8A MTS sequence is in
orange. (B) Confocal immunoﬂuorescent microscopy of cells expressing MTS-COX8A-hCas9. C – control non-transfected cells,
T – transiently transfected cells. (C) Detection of hCas9 in cells and mitochondria by western immunoblotting. PK, mitochondria
were treated with proteinase K. @eno – antibodies against enolase. (D) In vitro cleavage activity of the hCas9 in the presence of
mito-gRNAs on fragments of mtDNA. “C” corresponds to the control mtDNA fragment, which does not contain the target
sequence; “T” – to that containing the target sequence. (E) Cleavage activity of the hCas9 extracted from isolated mitochondria
(mito-lysate) compared to recombinant protein (Rec hCas9). (F) Nucleoid mtDNA cleavage by recombinant hCas9 detected by
southern-hybridization. Possible predicted cleavage products are shown at the right. The orange line indicates the hybridization
primer; the red bar – BlpI cleavage site. First panel at the left represents the cleavage products of puriﬁed mtDNA; mito-gRNAs
used in the test are shown above the panels.
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Rex-MTSCOX8A-hCas9 followed by transient transfection with
mito-gRNAs. When KSS cybrid cells were transfected with one
mito-gRNA targeting the border of the KSS deletion, we did not
observe any signiﬁcant shift of the mutant mtDNA proportion
(Fig. 3A). No signiﬁcant effect was observed on mtDNA content
when the Cyt-b gene region of wild type mtDNA was addressed
either (Fig. 3B). In contrast, when two mito-gRNAs, one target-
ing the NCR of mtDNA and the second – a sequence in the Cyt-b
gene, were applied simultaneously, we observed a reproducible
depletion of mtDNA by 2–3 times compared to the control
(Fig. 3C,D). The more important effect was demonstrated in
HEK293-T-Rex-MTSCOX8A-hCas9 cells transfected with gRNAs
bearing the 3’ F hairpin (Figs.1B and 3C). The similar mtDNA
depletion induced by the combination of two gRNAs was
obtained in transient co-transfection assays on another cell
type, HepG2 (Fig. 3D). We demonstrated a signiﬁcant decrease
of mtDNA copy number in the cells transfected simultaneously
with two gRNAs, but not in the cells transfected with each of
these gRNAs separately.
DISCUSSION
The main goal of this study was to demonstrate the feasibility to
establish a CRISPR-Cas9 system addressing human mtDNA and
based on the RNA mitochondrial import pathway. We obtained
clear evidence that the Cas9 enzyme can be adapted to mito-
chondria and that it is able to cleave speciﬁcally a variety of
mtDNA targets in vitro. We also created several guide RNAs
able to be targeted in human mitochondria due to short addi-
tional hairpin structures that we previously characterized as
import determinants (29, 30, 33). So far, neither of the single
target mt-gRNAs was able to inﬂuence the mtDNA content and
there was no expected shift when one mtDNA species was spe-
ciﬁcally targeted in the heteroplasmic context. It was recently
demonstrated that cleaved mtDNA molecules are rapidly
degraded in vivo (34, 35). According to this ﬁnding, all our
attempts to detect either point mutations or insertions–deletions
at the cleavage sites or to visualize the mtDNA fragments corre-
sponding to the targeted regions were unsuccessful (data not
shown). Nevertheless, we reproducibly were able to induce sig-
niﬁcant mtDNA depletion when two mtDNA regions were tar-
geted simultaneously.
Of note, one of these regions was the NCR of the mtDNA,
bearing the classical origin of the H-strand replication and pro-
moter regions for both strands’ transcription. NCR was shown
to have a very particular structure; its large part often incorpo-
rates a third linear DNA strand, which forms a stable displace-
ment (D-) loop. Other mtDNA molecules contain RNA as a third
FIG 3
In vivo effect of mitochondrial crispr-hcas9 system. Levels of heteroplasmy in KSS cybrid cells (A) and mtDNA copy number in
cells transfected with vector expressing the MTSCOX8A-hCas9 protein together with mito-gRNAs (A, D) or in cells expressing
MTSCOX8A-hCas9 in inducible way (B, C). (A) KSS heteroplasmy levels (% of mutant mtDNA), gRNAs indicated below the graphs;
NT, nontransfected KSS cybrid cells; D1 and D7, days after transfection. (B) relative mtDNA copy number HEK293-T-Rex-
MTSCOX8A-hCas9 cells, gRNAs are indicated at the right, time after protein induction and transfection with a gRNA – below the
graphs. (C) mtDNA copy number decrease in HEK293-T-Rex-MTSCOX8A-hCas9 cells in 48 h after the protein induction and trans-
fection with two gRNAs, as indicated. (D) mtDNA copy number in HepG2 cells transfected with vector expressing the MTSCOX8A-
hCas9 protein and with one or two gRNAs, as indicated below the graphs. Error bars correspond to two (for B) or three indepen-
dent experiments. Statistical differences were determined with a two-tailed Student’s t-test, P-values are indicated.
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strand, which is complementary to D-loop DNA (36). Conserved
sequence blocks of the human NCR were characterized by the
presence of stable G-quadruplex structures ((37, 38)). The func-
tion of the NCR is still poorly understood. This region can be
involved in mtDNA topology and segregation and its association
with the inner mitochondrial membrane (39). Taken together
our in vitro and in vivo data, one can suggest that the docking
of the hCas9/gRNA complex in the NCR might disturb the D-loop
formation, mtDNA replication or/and topology, which can be a
prerequisite for the successful mtDNA cleavage by a second
hCas9/gRNA complex located in the Cyt b gene region. Thus, if
even the hCas9/NCR gRNA complex cannot cleave mtDNA
in vitro, its action on the triple-strand D-loop (or alternatively
R-loop) structure can make another mtDNA region accessible
for the cleavage, thus inducing further rapid degradation and
mtDNA depletion.
Another interesting hypothesis is generated by recent
report claiming that the temperature in functional mitochon-
dria might be much higher than in the rest of the cell (40),
which can also explain why the system working so well in
nucleus is only partially active in the organelle. As a matter of
fact, the overall functionality of the RNP complex leading to the
cleavage of the DNA molecule may be somehow affected at 50.
Moreover, due to high AT-content of mtDNA, the most of the
possible target sequences (N20GG) are characterized by pre-
dicted Tm < 50, which can disturb the gRNA annealing with
mtDNA target. It was indeed demonstrated that at different
temperatures the CRISPR-Cas9 system may be affected – low
temperature decrease its efﬁciency, whereas higher – enhance
the off-target effect (41). To resolve these obstacles, one might
imagine to create new enzymes with better abilities than
Cas9 at elevated temperature, and to test them in a similar way
we did in this study, for example modiﬁed thermo-stable Cas9
versions may be used (42). As the temperature issue can affect
the extent of the off-target cleavages, and taking into account
that natural small-, medium- or large-size noncoding RNA may
be present in mitochondria (4, 43–45), one could expect that
the presence of active Cas9 enzyme can induce additional
cleavages of mtDNA in the absence of gRNAs. Without ruling
out such a possibility, our results are rather against this
hypothesis. Indeed, as it is shown on Fig. 3C,D, both transient
and induced expression of MTSCOX8A-hCas9 do not signiﬁcantly
inﬂuence mtDNA copy number. Finally, it is worth to mention
that our previous assays in the frame of the anti-replicative
strategy to address heteroplasmic mtDNA mutations proved to
be more effective when imported recombinant RNAs with
higher melting temperatures were applied (29, 46, 47), which
can indirectly indicate that the temperature issue is to be seri-
ously taken into account also for CRIPRization.
The last but not least important point is that the RNA
import is a widely spread process (4), so far it is not efﬁcient,
meaning that only a minor part of the cellular pool of a given
imported RNA reaches the matrix compartment. This intrinsi-
cally low efﬁciency of the pathway and often still not eluci-
dated functions of the imported RNA species generated recent
doubts about the usefulness of this mechanism for correction
of mtDNA deﬁciencies. So far, many of our data indicate on a
clear possibility to exploit it for both allotropic and anti-
replication strategies (25–30). To counter the problem of low
efﬁciency, new RNA molecules can be created with greater
mitochondrial import capacities, and our previous reports
indicate that it is possible. As a matter of fact, our recent stud-
ies with 5S rRNA based RNA vectors clearly are supporting
this strategy, as increasing expression and import of recombi-
nant RNA also produce a more pronounced anti-replication
effect on mtDNA (47). All in all, we believe that the current
study provides matter to be moderately optimistic about the
possibility of CRISPRization of human mitochondrial DNA. If
even this system cannot cleave mutant mtDNA in speciﬁc way,
our ﬁndings indicate that it might be developed for the future
mtDNA editing strategies.
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